Oct 30, 2024
1:40
For every 40 shares held, investors received 1. The price per share adjusted from $0.85 to $33.92.
The split itself did not change the total investment value.
ExpreS2ion Biotech Holding AB (STO:EXPRS2) operates in the Biotechnology industry.
ExpreS2ion Biotech Holding AB company overviewExpreS2ion Biotech Holding AB's most recent stock split was on October 30, 2024. It was a 1-for-40 reverse split, so shareholders received 1 share for every 40 they held.
ExpreS2ion Biotech Holding AB (STO:EXPRS2) has split its stock 6 times: a 110-for-109 split on August 4, 2017, a 162-for-157 split on February 1, 2018, a 27-for-25 split on September 30, 2020, a 40-for-39 split on April 12, 2022, a 43-for-40 split on March 24, 2023, and a 1-for-40 reverse split on October 30, 2024.
ExpreS2ion Biotech Holding AB has split its stock 6 times. This history records 6 splits between August 4, 2017 and October 30, 2024.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In ExpreS2ion Biotech Holding AB's 1-for-40 reverse split on October 30, 2024, every 40 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
ExpreS2ion Biotech Holding AB has not announced a new split in our records. Its most recent split was on October 30, 2024, 1 year ago. Companies announce splits in advance, and any new STO:EXPRS2 split will appear on this page.
Already premium?